Where Will Vertex Pharmaceuticals Be in 5 Years

A lot can change in five years. Take Vertex Pharmaceuticals (NASDAQ: VRTX), for example. In late 2020, the big biotech ...
pharmaphorum

After four-year wait, patients in England finally get Vertex's cystic fibrosis drugs

NHS England has signed an agreement with US pharma Vertex covering all the company’s licensed cystic fibrosis medicines, and any future uses for them. The deal follows a three-year stand off between ...

Fern stems reveal secrets of evolution – how constraints in development can lead to new forms

Is an organism a sum of its parts, or should they be considered as a whole? New research on ferns shows how the way scientists understand evolution affects how they study life.
MarketWatch

Crispr Therapeutics, Vertex get FDA approval for breakthrough gene-editing treatment

Crispr Therapeutics AG CRSP and Vertex Pharmaceuticals Inc. VRTX on Friday got U.S. regulatory approval for a sickle-cell disease treatment based on the transformative gene-editing technology Crispr.
Barchart on MSN

Is Vertex Pharmaceuticals Stock Underperforming the Nasdaq?

Vertex Pharmaceuticals Incorporated (VRTX), based in Boston, Massachusetts, is a prominent biotech firm specializing in the discovery, development, and commercialization of innovative small-molecule ...
Mother Jones

It’s the Inequality, Stupid

Want more charts like these? See our charts on the secrets of the jobless recovery, the richest 1 percent of Americans, and how the superwealthy beat the IRS. How Rich Are the Superrich? A huge share ...